We use cookies to measure traffic and show relevant ads. By clicking Accept you agree to our use of analytics and advertising cookies.
FDA批准了首个针对不适合化疗的急性髓系白血病患者的全口服方案。了解INQOVI+venetoclax联合疗法如何改变治疗和生活质量。详情及市场展望。